Securing Leadership in Biotechnology & Advanced Biomanufacturing
The Advanced Regenerative Manufacturing Institute (ARMI) is a Department of Defense-sponsored Manufacturing Innovation Institute, advancing the U.S. bioeconomy by enabling scalable, secure, and cost-effective production of regenerative medicine technologies. Through its program BioFabUSA, ARMI is accelerating the development of critical biotechnologies and building a domestic ecosystem for advanced biomanufacturing that supports national security, health resilience, and economic growth.
BiofabUSA
BioFabUSA, a public-private partnership with more than 170 members across industry, academia, and government, is driving technical and strategic leadership in the development and manufacturing of cell, tissue, and organ-based products. The institute’s work strengthens domestic supply chains, supports dual-use technology development, and prepares a skilled workforce to meet the demands of a growing, globally competitive bioeconomy.
ARMI BioIndustries
ARMI BioIndustries is the development, manufacturing, and commercialization arm of the Advanced Regenerative Manufacturing Institute (ARMI). It provides full-service support to advance regenerative medicine technologies from concept to production—offering the infrastructure, expertise, and capabilities needed to bring innovative biomanufacturing solutions to market.
NextFab
NextFab is the first Foundry for American Biotechnology, established to strengthen the nation’s health security and accelerate biotechnology innovation. Its mission is to support the development of technologies that help the United States prepare for and respond to health-related threats, improve everyday medical care, and expand domestic capacity for advanced biomanufacturing.
BioFabUSA Membership
As an ARMI | BioFabUSA member, your organization becomes part of a national network driving the future of regenerative medicine and advanced manufacturing.
Members benefit from the collective expertise and capabilities of partners across industry, academia, government, and nonprofits. Together, we are building the technologies, standards, and workforce needed to transition tissue engineering and regenerative medicine from research to scalable, commercially viable solutions.
Membership provides opportunities to collaborate, access shared resources, and stay at the forefront of innovation in a field critical to U.S. health, economic, and national security priorities.
News
Exciting Partnership with the Museum of Science, Boston!
ARMI | BioFabUSA is partnering with the Museum of Science, Boston to showcase how biofabrication is shaping the future of healthcare.
Events
2025 BioFab Investment Summit
Manchester, NH Manchester, New HampshireHosted by the BioFab Startup Lab, the 2025 BioFab Investment Summit connects early-stage companies with investors and partners driving regenerative medicine forward.
TERMIS-AM 2025
Detriot, MI Detroit, MI, United StatesARMI will present at TERMIS 2025, highlighting cutting-edge regenerative medicine research and its role in scaling biomanufacturing through national collaboration.
Defense Manufacturing Conference (DMC) 2025
Caribe Royale Orlando 8101 World Center Drive, Orlando, FL, United StatesBioFabUSA will exhibit and present at DMC 2025, sharing how scalable biomanufacturing can strengthen U.S. defense capabilities and support resilient manufacturing systems.
Rockwell Automation Fair 2025
McCormick Place Convention Center 2317 S. Indiana Ave., Chicago, IL, United StatesARMI sponsors Rockwell Automation Fair 2025 to explore smart manufacturing technologies and digital transformation in biomanufacturing and regenerative medicine.
“There are hurdles that need to be overcome with tissue and organs for human transplant, and sometimes the traditional connection between industry and academia can be slow going. ARMI | BioFabUSA can accelerate this.”
David Brafman
Associate Professor at Arizona State University
